Divyan Chopra
Overview
Explore the profile of Divyan Chopra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sultan I, Waterhouse D, Chopra D, Lonshteyn A, Weycker D, Delea T, et al.
Adv Ther
. 2024 Oct;
41(12):4648-4659.
PMID: 39470877
Introduction: Sotorasib was the first drug approved for adults with Kirsten rat sarcoma G12C-mutated locally advanced/metastatic non-small cell lung cancer (NSCLC) who received prior systemic therapy in the US. This...
2.
Acharya M, Chopra D, Smith A, Fritz J, Martin B
J Chiropr Med
. 2022 Jul;
21(2):67-76.
PMID: 35774633
Objective: The objective of this study was to estimate the association between early use of physical therapy (PT) or chiropractic care and incident opioid use and long-term opioid use in...
3.
Chopra D, Li C, Painter J, Bona J, Nookaew I, Martin B
J Pain
. 2021 Jun;
22(12):1681-1695.
PMID: 34174385
Increasing emphasis on guidelines and prescription drug monitoring programs highlight the role of healthcare providers in pain treatment. Objectives of this study were to identify characteristics of key players and...
4.
Estes S, Soliman A, Zivkovic M, Chopra D, Zhu X
Womens Health (Lond)
. 2020 Dec;
16:1745506520965898.
PMID: 33357086
Objectives: Evaluate all-cause and endometriosis-related health care resource utilization and costs among newly diagnosed endometriosis patients with high-risk versus low-risk opioid use or patients with chronic versus non-chronic opioid use....
5.
Estes S, Soliman A, Zivkovic M, Chopra D, Zhu X
Adv Ther
. 2020 May;
37(6):2777-2791.
PMID: 32399813
Introduction: To compare all-cause and endometriosis-related healthcare resource utilization (HCRU) and healthcare costs by service categories (outpatient, inpatient, emergency room [ER], pharmacy) among patients with newly diagnosed endometriosis using opioids...
6.
Acharya M, Chopra D, Hayes C, Teeter B, Martin B
Value Health
. 2020 Apr;
23(4):451-460.
PMID: 32327162
Objectives: To determine the cost-effectiveness of pharmacy-based intranasal naloxone distribution to high-risk prescription opioid (RxO) users. Methods: We developed a Markov model with an attached tree for pharmacy-based naloxone distribution...
7.
Ray-Griffith S, Chopra D, Stowe Z, Martin B
Contraception
. 2019 Feb;
99(5):296-299.
PMID: 30763579
Objective: To describe claims for contraceptive services among reproductive-aged women filling chronic opioid prescriptions. Study Design: Using a large US commercial claims database, IMS Lifelink+, we identified women aged 15-44 ...
8.
Hammond D, Ficek O, Painter J, McCain K, Cullen J, Brotherton A, et al.
Pharmacotherapy
. 2018 Mar;
38(5):531-538.
PMID: 29600824
Purpose: Delays in achieving target mean arterial pressure (MAP) are associated with increased morbidity and mortality in patients with septic shock. This trial was conducted to test the hypothesis that...
9.
Hammond D, Cullen J, Painter J, McCain K, Clem O, Brotherton A, et al.
J Intensive Care Med
. 2017 Aug;
34(11-12):910-916.
PMID: 28820036
Background: Delays in achievement of target mean arterial pressure (MAP) have been associated with increased mortality in patients with septic shock. Vasopressin may be added to norepinephrine to raise MAP...
10.
Hammond D, McCain K, Painter J, Clem O, Cullen J, Brotherton A, et al.
J Intensive Care Med
. 2017 Jun;
34(10):805-810.
PMID: 28618919
Background: Guidance for the discontinuation of vasopressors in the recovery phase of septic shock is limited. Norepinephrine is more easily titrated; however, septic shock is a vasopressin deficient state, which...